Latest Press Releases
View all
TimeHeadline
2h agoThe Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet
Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H
2h agoKelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO
Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H
2h agoMax Power Mining Closes $25 Million Strategic Investment From Eric Sprott To Accelerate Commercial Evaluation at Lawson
Max Power Mining Corp
3h agoMach Travel Solutions Delivers Sustained FY26 Performance Despite Challenging Macro- Economic Environment; While Accelerating Transformation into an Integrated Travel Solutions Platform
Mach Conferences And Events Ltd.
3h agoVanta Announces Strategic Private Placement Financing to Advance U.S. Peptide Market Entry and Integrated Longevity and Consumer Health Sciences Platform
Vanta Holdings Inc.
Polkastarter logo

Polkastarter

About

Polkastarter — investor relations, events, news, and company updates on 6ix.

Community Chat

Ask AI

Try asking